Citation Impact
Citing Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
2005 Standout
Favorable Prognostic Impact of NPM1 Mutations in Older Patients With Cytogenetically Normal De Novo Acute Myeloid Leukemia and Associated Gene- and MicroRNA-Expression Signatures: A Cancer and Leukemia Group B Study
2009
The Endogenous Tryptophan Metabolite and NAD+ Precursor Quinolinic Acid Confers Resistance of Gliomas to Oxidative Stress
2013
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7
2021 StandoutNobel
A Novel Germline Variant in CSF3R Reduces N-Glycosylation and Exerts Potent Oncogenic Effects in Leukemia
2018 StandoutNobel
Sample processing obscures cancer-specific alterations in leukemic transcriptomes
2014
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity
2010
Evolution of the Cancer Stem Cell Model
2014 Standout
Ferroptosis: molecular mechanisms and health implications
2020 Standout
SCANPY: large-scale single-cell gene expression data analysis
2018 Standout
CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
2009
Human serum albumin interaction with oxaliplatin studied by capillary isoelectric focusing with the whole column imaging detection and spectroscopic method
2008
Determining cell type abundance and expression from bulk tissues with digital cytometry
2019 Standout
Post-remission therapy for acute myeloid leukemia
2014
Autoimmune Complications of Chronic Lymphocytic Leukemia
2006
Association of a Leukemic Stem Cell Gene Expression Signature With Clinical Outcomes in Acute Myeloid Leukemia
2010
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
2009 Standout
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
2012 Standout
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
2011 StandoutNature
Cytogenetics in acute leukemia
2003
VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer
2017 StandoutNobel
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Characterization of CEBPA mutations and promoter hypermethylation in pediatric acute myeloid leukemia
2010
Immunogenic cell death in cancer and infectious disease
2016 Standout
Oxaliplatin-induced neurotoxicity is mediated through gap junction channels and hemichannels and can be prevented by octanol
2015
The molecular machinery of regulated cell death
2019 Standout
Organization and Evolution of Brain Lipidome Revealed by Large-Scale Analysis of Human, Chimpanzee, Macaque, and Mouse Tissues
2015 StandoutNobel
Molecular mechanisms of cisplatin resistance
2011 Standout
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
2013 StandoutNobel
PrognoScan: a new database for meta-analysis of the prognostic value of genes
2009
The single-cell transcriptional landscape of mammalian organogenesis
2019 StandoutNature
Translational implications of somatic genomics in acute myeloid leukaemia
2014
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia
2009
Stem cell gene expression programs influence clinical outcome in human leukemia
2011
HMGB1 in health and disease
2014
New trends for metal complexes with anticancer activity
2008 Standout
Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis
2015
Biology and management of relapsed acute myeloid leukaemia
2005
Micellar electrokinetic capillary chromatography quantification of cytosine arabinoside and its metabolite, uracil arabinoside, in human serum
2001
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
Molecular genetics in acute myeloid leukemia
2010
Axonal excitability changes and acute symptoms of oxaliplatin treatment: In vivo evidence for slowed sodium channel inactivation
2017
Determination of intact oxaliplatin in human plasma using high performance liquid chromatography-tandem mass spectrometry
2008
Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy
2018 StandoutNobel
Dictionary learning for integrative, multimodal and scalable single-cell analysis
2023 Standout
Analysis of anticancer drugs: A review
2011 Standout
The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia
2001
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Chemotherapy Dosing Part I: Scientific Basis for Current Practice and Use of Body Surface Area
2006
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
RhoGAPs Attenuate Cell Proliferation by Direct Interaction with p53 Tetramerization Domain
2013
Dimensionality reduction for visualizing single-cell data using UMAP
2018 Standout
The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial
2001
Artificial Intelligence in Cardiology
2018 Standout
New cancer targets emerging from studies of the Von Hippel‐Lindau tumor suppressor protein
2010 StandoutNobel
Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation
2006
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade
2017 StandoutNobel
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
2019 Standout
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Bioluminescent sensor proteins for point-of-care therapeutic drug monitoring
2014 StandoutNobel
Intensive chemotherapy is not recommended for patients aged >60 years who have myelodysplastic syndromes or acute myeloid leukemia with high‐risk karyotypes
2007
Comprehensive Integration of Single-Cell Data
2019 Standout
Autologous peripheral blood stem cell transplantation for acute myeloid leukemia
2011
The prognostic landscape of genes and infiltrating immune cells across human cancers
2015 Standout
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
2017 Standout
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
2020 Standout
Clinical Relevance of Circulating Nucleosomes in Cancer
2008
An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance
2011
Therapeutic drug monitoring of cytotoxic drugs
2001
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Therapeutic drug monitoring of cytotoxic drugs
2001
The side effects of platinum-based chemotherapy drugs: a review for chemists
2018 Standout
Molecular Genetics of Adult Acute Myeloid Leukemia: Prognostic and Therapeutic Implications
2011
Acute Myeloid Leukemia
2015 Standout
An Update on Hepatic Arterial Infusion Chemotherapy for Colorectal Cancer
2003
Multilineage dysplasia does not influence prognosis in CEBPA-mutated AML, supporting the WHO proposal to classify these patients as a unique entity
2012
Mutational spectrum of acute myeloid leukemia patients with double CEBPA mutations based on next-generation sequencing and its prognostic significance
2018
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
Interactions of Antitumor Metallodrugs with Serum Proteins: Advances in Characterization Using Modern Analytical Methodology
2006
Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34− fraction
2010
Cancer treatment and survivorship statistics, 2016
2016 Standout
Chemo-genomic interrogation of CEBPA mutated AML reveals recurrent CSF3R mutations and subgroup sensitivity to JAK inhibitors
2016
How I treat refractory and early relapsed acute myeloid leukemia
2015
The prognostic and functional role of microRNAs in acute myeloid leukemia
2010
Cancer treatment and survivorship statistics, 2019
2019 Standout
Age-Specific Differences in Oncogenic Pathway Dysregulation in Patients With Acute Myeloid Leukemia
2009
A single splice site mutation in human-specific ARHGAP11B causes basal progenitor amplification
2016 StandoutNobel
The relative utilities of genome-wide, gene panel, and individual gene sequencing in clinical practice
2017
Chemical Inhibition of ENL/AF9 YEATS Domains in Acute Leukemia
2021 StandoutNobel
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Prognostic Significance of CEBPA Mutations in a Large Cohort of Younger Adult Patients With Acute Myeloid Leukemia: Impact of Double CEBPA Mutations and the Interaction With FLT3 and NPM1 Mutations
2010
Repetitive Cycles of High-Dose Cytarabine Benefit Patients With Acute Myeloid Leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): Results from CALGB 8461
2004
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
IDH1 and IDH2 Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
2010
Dose-finding and pharmacologic study of chronic oral idarubicin therapy in metastatic breast cancer patients.
2000
Prognostic Index for Adult Patients With Acute Myeloid Leukemia in First Relapse
2005
Dose translation from animal to human studies revisited
2007 Standout
Works of Jan Braess being referenced
Age-Related Risk Profile and Chemotherapy Dose Response in Acute Myeloid Leukemia: A Study by the German Acute Myeloid Leukemia Cooperative Group
2008
Acute Myeloid Leukemia With Biallelic CEBPA Gene Mutations and Normal Karyotype Represents a Distinct Genetic Entity Associated With a Favorable Clinical Outcome
2009
Modeling the Pharmacodynamics of Highly Schedule-Dependent Agents: Exemplified by Cytarabine-Based Regimens in Acute Myeloid Leukemia
2005
NPM1 but not FLT3-ITD mutations predict early blast cell clearance and CR rate in patients with normal karyotype AML (NK-AML) or high-risk myelodysplastic syndrome (MDS)
2009
Cytidine deaminase - the methodological relevance of AraC deamination for ex vivo experiments using cultured cell lines, fresh leukemic blasts, and normal bone marrow cells
1999
Chemomodulation of sequential high-dose cytarabine by fludarabine in relapsed or refractory acute myeloid leukemia: a randomized trial of the AMLCG
2013
Proliferative activity of leukaemic blasts and cytosine arabinoside pharmacodynamics are associated with cytogenetically defined prognostic subgroups in acute myeloid leukaemia
2001
Multivariate analysis of prognostic factors in patients with refractory and relapsed acute myeloid leukemia undergoing sequential high-dose cytosine arabinoside and mitoxantrone (S-HAM) salvage therapy: relevance of cytogenetic abnormalities
2000
A phase I/II study of oral etoposide and idarubicin in elderly patients with high-risk acute myeloid leukemia unable to undergo intensive chemotherapy
2004
Phase I and pharmacokinetic study of hepatic arterial infusion with oxaliplatin in combination with folinic acid and 5-fluorouracil in patients with hepatic metastases from colorectal cancer
2001
Expression analysis of genes located in the minimally deleted regions of 13q14 and 11q22‐23 in chronic lymphocytic leukemia—unexpected expression pattern of the RHO GTPase activator ARHGAP20
2011
Cytogenetic subgroups in acute myeloid leukemia differ in proliferative activity and response to GM-CSF
2001
Detection and determination of the major metabolites of [3H]cytosine arabinoside by high-performance liquid chromatography
1996
Rapid and sensitive screening for CEBPA mutations in acute myeloid leukaemia
2008
Mucocutaneous autoimmune syndrome following fludarabine therapy for low-grade non-Hodgkin's lymphoma of B-cell type (B-NHL)
1997
Early prediction of therapy response in patients with acute myeloid leukemia by nucleosomal DNA fragments
2006
An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia
2008
High expression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in cytogenetically normal acute myeloid leukemia
2012
Oxaliplatin pharmacokinetics during a four-hour infusion.
1999
ERG Expression Is an Independent Prognostic Factor and Allows Refined Risk Stratification in Cytogenetically Normal Acute Myeloid Leukemia: A Comprehensive Analysis of ERG, MN1, and BAALC Transcript Levels Using Oligonucleotide Microarrays
2009
Oral idarubicin pharmacokinetics--correlation of trough level with idarubicin area under curve.
1996
The FLT3ITD mRNA level has a high prognostic impact in NPM1 mutated, but not in NPM1 unmutated, AML with a normal karyotype
2012